Moreover, the genetic variants of RAD51B may contribute to the susceptibility of cancer, as shown in the cases of breast cancer 5, 6, 7, 8, nasopharyngeal carcinoma 9, glioma 10, and cutaneous melanoma 11. This evidence concerns the gene RAD51B and central nervous system cancer.